Gefapixant Citrate NEW
| Price | Get Latest Price | ||
| Package | 1kg | 10kg | 25kg |
| Min. Order: | 0.009999999776482582kg |
| Supply Ability: | 100kg |
| Update Time: | 2025-08-05 |
Product Details
| Product Name: Gefapixant Citrate | CAS No.: 2310299-91-1 |
| Min. Order: 0.009999999776482582kg | Purity: 98% |
| Supply Ability: 100kg | Release date: 2025/08/05 |
Gefapixant Citrate, CAS RN 2310299-91-1
Gefapixant, CAS RN 1015787-98-0
White to off-white crystalline powder or granular solid
Purity NLT 99%
Manufacturer | Large Inventory | Ready Stock | Immediate Dispatch
Company Profile Introduction
Beijing Ruqueen Biotech.,Co., Ltd.?is a high-tech enterprise integrating the R&D and business promotion of novel food ingredients, APIs and intermediates, and novel pharmaceutical excipients. The company advocates a green, eco-friendly, and differentiated approach to health and wellness, emphasizing RSM(Regulatory Starting Material) research and QbD (Quality by Design) process development to ensure economical, environmentally friendly, safe, and quality-controllable manufacturing processes.
The company operates a?1,000+ square meter R&D center?in the Beijing Economic-Technological Development Area (BDA), housing departments for process development, pilot-scale conversion, commercial production, quality research, and business promotion.
The center's team comprises?Ph.D. and M.S. holders in chemistry?with over 20 years of commercial production experience in APIs. It is equipped with multiple advanced instruments including: 50/100L glass reactors, 20L rotary evaporators, HPLC, IR, LC-MS, GC-MS. Additionally, the company maintains?stable cooperative manufacturing bases?in Tianjin City, Hebei Province, Shandong Province, Inner Mongolia Autonomous Region, and other regions, enabling scaled commercial production.
The company conducts R&D and commercial manufacturing of: Complex active pharmaceutical ingredients (APIs), Pharmaceutical intermediates, Novel food ingredients and Advanced pharmaceutical excipients
The company provides comprehensive services including:
? Registration filing support for APIs/excipients (e.g., DMF/CEP preparation)
? Process optimization for existing pharmaceutical materials
? Enabling "API + Formulation" integration strategies for pharmaceutical partners
Intellectual Property Achievements:
? 3 authorized invention patents
? 8 pending patent applications (including 2 PCT international filings)
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $238.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-10-15 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2025-01-07 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-07-24 |

China